Clinical Trials Directory

Trials / Conditions / Atrophy

Atrophy

36 registered clinical trials studyying Atrophy4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingInvestigation of Respiratory Muscle Sarcopenia in Adults Diagnosed With Diabetes
NCT07002333
Kirsehir Ahi Evran Universitesi
Enrolling By InvitationPRF vs. Graftless Sinus Lift With Implant Placement
NCT07090694
Dar Al Uloom UniversityPhase 1
RecruitingInfluence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Fe
NCT05869812
University of Kansas Medical CenterPhase 2
Active Not RecruitingA Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Stud
NCT05698316
Association for Innovation and Biomedical Research on Light and Image
Active Not RecruitingLong-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
NCT05626855
Scholar Rock, Inc.Phase 3
UnknownImpact of Postprandial 'Exercise Snacks' on Protein and Glucose Metabolism Following a Period of Step Reductio
NCT05810272
University of TorontoN/A
CompletedEfficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinerse
NCT05156320
Scholar Rock, Inc.Phase 3
SuspendedExtreme Lateral Interbody FusionFUSION (XLIF) Versus Posterior Lumbar Interbody Fusion (PLIF)
NCT04589572
Hasselt UniversityN/A
CompletedAn Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy
NCT03921528
Scholar Rock, Inc.Phase 2
CompletedEffect of Blood Flow Restriction Training on Patient With Anterior Cruciate Ligament Reconstruction
NCT04284748
Hacettepe UniversityN/A
CompletedHistology and Ultrasound Pilot Study of HA Gels Adipose Tissue
NCT02868749
Vandeputte, Joan, M.D.N/A
CompletedThe Effect of Different Gingival Biotypes on Dimensional Stability of Free Gingival Graft
NCT03616197
Istanbul Aydın UniversityN/A
CompletedComparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy
NCT02770365
Padagis LLCPhase 3
CompletedProspective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (Fem
NCT02747641
Alma Lasers Inc.N/A
UnknownBuccal Fat Pad Derived Stem Cells With Cortical Tenting in Posterior Mandible Reconstruction
NCT02745366
Shahid Beheshti University of Medical SciencesPhase 1
CompletedQuantifying Quadriceps Atrophy Following Tibial Plateau Fracture
NCT02781623
NYU Langone Health
CompletedComparative Results of Six Biomaterials Used in Two-stage Maxillary Sinus
NCT03496688
University of Roma La SapienzaN/A
UnknownHO-1 and Muscle Mitochondrial Dysfunction in Sepsis
NCT02359240
Changhai Hospital
CompletedAn Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy
NCT02497547
PepTonic Medical ABPhase 2
CompletedSparing of the Fovea in Geographic Atrophy Progression
NCT02332343
University Hospital, Bonn
RecruitingA Modified Sinus Floor Elevation Technique - a Pilot Study on 12 Patients
NCT02137824
Medical University of ViennaN/A
UnknownEvaluation of Thermal-Aided Muscle Stimulation
NCT01911312
Niveus Medical, Inc.N/A
CompletedMorphological and Functional Evaluation of Buttock Lipoatrophy Treatment With Macrolane
NCT00931268
Galderma R&DN/A
CompletedEfficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Asso
NCT00729469
ShionogiPhase 3
WithdrawnMuscle Atrophy in Sepsis
NCT00583206
Gregory A. Schmidt
CompletedA Clinical Study to Evaluate the Safety of Ospemifene
NCT00566982
ShionogiPhase 3
CompletedA Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atro
NCT00630539
ShionogiPhase 2
CompletedResistance Training in Elderly
NCT00744094
Maastricht University Medical CenterPhase 1 / Phase 2
CompletedLeucine Supplementation in Elderly Men
NCT00807508
Maastricht University Medical CenterPhase 1 / Phase 2
CompletedLong-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrop
NCT01585558
ShionogiPhase 3
CompletedLong-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in
NCT01586364
ShionogiPhase 3
TerminatedEffect of Exercise on Risk-factors of Elderly Women
NCT00267839
University of Erlangen-Nürnberg Medical SchoolPhase 3
TerminatedEffect of Whole Body Vibration on Bone and Fall Related Parameters
NCT00292916
University of Erlangen-Nürnberg Medical SchoolPhase 3
CompletedA Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
NCT00276094
ShionogiPhase 3
CompletedStudy Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis
NCT00137371
Wyeth is now a wholly owned subsidiary of PfizerPhase 3
CompletedPostmenopausal Facial Skin After Estradiol and Genistein Topical Treatment
NCT01553773
Federal University of São PauloPhase 2